Kratom Research Institute

News · 2026-02-12

Michigan's Kratom Debate: How One State Is Trying to Regulate the Plant Without Abandoning Chronic Pain Patients

Source: Bridge Michigan

Why it matters

Michigan's debate captures the central tension in kratom policy nationwide: how to restrict dangerous high-potency 7-OH products without cutting off the millions of Americans — including chronic pain and opioid recovery patients — who rely on natural kratom.

The big picture

Michigan House Bill 4969, the Kratom Consumer Protection Act, seeks to regulate (not ban) kratom by imposing age restrictions, packaging requirements, and third-party testing — while effectively banning high-concentration 7-OH products with a 2% potency limit. Addiction experts warn that 7-OH is already derailing years of opioid recovery for patients, while users like Melody Woolf, 61, say daily kratom use gave them back their lives. The bill's fate mirrors the broader national conflict between harm reduction and consumer protection.

Key findings

What they say

"A drug like 7-OH — that has the potential to really derail us," said Sean Esteban McCabe, director of the Center for the Study of Drugs, Alcohol, Smoking and Health at the University of Michigan's School of Nursing.

Bottom line

Michigan's kratom debate illustrates why policy is so hard: the same plant that helps chronic pain patients and opioid recovery users can — in its concentrated 7-OH form — send those same people back into addiction.